Tofacitinib Tablet
Product Images NDC 51991-963

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 51991-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Tofacitinib 01)

Chemical Structure (Tofacitinib 01)
FDA Label Image

Figure 1 (Tofacitinib 02)

Figure 1 (Tofacitinib 02)
This text includes information related to factors, ratios, and confidence intervals. It seems to be a part of a statistical analysis or study. It mentions intrinsic factors and their relationship to a reference value. The concept of ratios and confidence intervals is also present in the text.*
FDA Label Image

Figure 2 (Tofacitinib 03)

Figure 2 (Tofacitinib 03)
FDA Label Image

Figure 3 (Tofacitinib 04)

Figure 3 (Tofacitinib 04)
FDA Label Image

Figure 4 (Tofacitinib 05)

Figure 4 (Tofacitinib 05)
FDA Label Image

Figure 5 (Tofacitinib 06)

Figure 5 (Tofacitinib 06)
FDA Label Image

Figure 6 (Tofacitinib 07)

Figure 6 (Tofacitinib 07)
FDA Label Image

Figure 7 (Tofacitinib 08)

Figure 7 (Tofacitinib 08)
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
Store Tofacitinib Tablets at 20°C to 25°C (68°F to 77°F). Each tablet contains Tofacitnib mg (equivalent to 8.08 mg Tofacitnid Citrate). The tablets are pharmaceutical products distributed by Breckenridge Pharmaceuticals. Pharmacists are advised to dispense the medication guide provided separately to each patient. For more information, see the accompanying prescribing information.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Store Tofacitinib Tablets at NDC 51991-963-06 in a cool and dry place between 20°C to 25°C (68°F to 77°F). Do not repackage this medication. It is distributed by Breckenridge Pharmaceutical, Inc. Manufactured by Towa Pharmaceutical Europe in Martorelles, Spain. Each tablet contains Tofacitinib Citrate, and the recommended dosage is 10 mg for Ulcerative Colitis. Make sure to dispense the Medication Guide provided separately to each patient. The total package contains 60 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.